Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Journal of Environmental Pathology, Toxicology and Oncology
Impact-faktor: 1.241 5-jähriger Impact-Faktor: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN Druckformat: 0731-8898
ISSN Online: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v29.i3.80
pages 255-265

Chemopreventive Action of Diclofenac in Dimethybenzanthracene Induced Lung Cancer in Female Wistar Rat

Poonam Thakur
Department of Biophysics, Panjab University, Chandigarh, India
Sankar Nath Sanyal
Department of Biophysics, Panjab University, Chandigarh, India 160014

ABSTRAKT

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to be effective antineoplastic agents that block prostaglandin formation by inhibiting the enzyme cyclooxygenase (COX), which exists in two isoforms, COX-1 and COX-2. COX-2 is over expressed in lung cancer. The present study evaluates the chemopreventive efficiency of diclofenac, which is a preferentially selective COX-2 inhibitor in lung cancer. Female Wistar rats were divided into 4 groups. Group 1 served as control and received saline intratracheally, once. In group 2 lung cancer was induced by a single intratracheal instillation of dimethybenz(a)anthracene (DMBA) (20 mg/kg body weight). Group 3 was given the intervention of diclofenac (8mg/kg body weight) daily by oral gavage, in addition to DMBA. Group 4 received diclofenac alone. After 18 weeks of treatment, animals were sacrificed and various studies done. COX-2 expression as seen by western immunoblot and immunohistochemistry (IHC) was increased in the DMBA group, while diclofenac intervention was able to bring down the levels of the enzyme. Apoptosis studies by DNA fragmentation, TUNEL and fluorescent dyes reveal the lowered number of apoptotic cells in group 2. The levels were restored by diclofenac treatment in group 3. There was also a significant reduction in tumor incidence in DMBA+Diclofenac treated animals. All these results indicate that diclofenac acts as an effective chemopreventive agent that mediates its effects by the induction of apoptosis in cancer tissue and suppression of COX-2 enzyme.

SCHLÜSSELWÖRTER: diclofenac, lung cancer, apoptosis, COX-2

Articles with similar content:

Nuclear Factor Kappa B: A Pro-Inflammatory, Transcription Factor−Mediated Signalling Pathway in Lung Carcinogenesis and Its Inhibition By Nonsteroidal Anti-Inflammatory Drugs
Journal of Environmental Pathology, Toxicology and Oncology, Vol.31, 2012, issue 1
Sankar Nath Sanyal, Shruti Setia
Induction of Apoptosis as a Potential Chemopreventive Effect of Dual Cycloxygenase Inhibitor, Diclofenac, in Early Colon Carcinogenesis
Journal of Environmental Pathology, Toxicology and Oncology, Vol.29, 2010, issue 1
Sankar Nath Sanyal, Jasmeet Kaur
Change in Nicotine-Induced VEGF, PGE2 AND COX-2 Expression Following COX Inhibition in Human Oral Squamous Cancer
Journal of Environmental Pathology, Toxicology and Oncology, Vol.31, 2012, issue 4
Bita Sedaghati, Masoumeh Esfahani, Mona Salimi, Mehrangiz Esfandiary, Hamid Reza Aslani, Narcis Habibzadeh, Sepideh Arbabi Bidgoli, Mohammad Hossein Ghahremani, Amir Amanzadeh
Radioprotection by Oral Administration of Aegle marmelos (L.) Correa In Vivo
Journal of Environmental Pathology, Toxicology and Oncology, Vol.24, 2005, issue 4
Ponemone Venkatesh, Ganesh Chandra Jagetia
The Cyclooxygenase-2 Inhibitor Etoricoxib Is a Potent Chemopreventive Agent of Colon Carcinogenesis in the Rat Model
Journal of Environmental Pathology, Toxicology and Oncology, Vol.28, 2009, issue 1
Sankar Nath Sanyal, Manpreet Kaur Saini, Pinky Sharma, Jasmeet Kaur